A potential surrogate marker of efficacy for a therapeutic melanoma vaccine.
Elliott
G T
GT
Ribi ImmunoChem Research, Inc., Hamilton, Montana 59840.
Perez
J
J
McLeod
R A
RA
Von Eschen
K B
KB
D015703:Antigens, CD / Q000276:immunology; D014408:Biomarkers, Tumor; D006801:Humans; D016233:Immunotherapy, Active / Q000379:methods; D016131:Lymphocyte Subsets / Q000276:immunology; D008545:Melanoma / Q000175:diagnosis* / Q000628:therapy; D016019:Survival Analysis
D015703:Antigens, CD; D014408:Biomarkers, Tumor